• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Association of rapid eye movement sleep with mortality in middle-aged and older adults

byBrian DoughertyandAlex Chan
July 16, 2020
in Chronic Disease, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Decreasing amounts of REM sleep was associated with an increased risk of all-cause mortality.

2. The most profound risk was seen among individuals experiencing less than 15% REM sleep at night.

Evidence Level Rating: 2 (Good)

Sleep disturbances affect tens of millions of adults each year, contributing significantly to the global burden of disease. Numerous studies have linked decreased sleep to mortality. Less, however, is known about how the proportion of time spent in rapid eye movement (REM) sleep and non-REM sleep stages (N1, N2, and N3) contribute to disease patterns, though it is well-established that decreased REM sleep is associated with poorer mental and physical health. This cross-sectional study of two independent cohorts – 2,675 patients (mean [SD] age at baseline = 76.3 [5.5] years, 100% male, 91.5% white) from the Outcomes of Sleep Disorders in Older Men (MrOS) Study and 1,386 patients (mean [SD] age at baseline = 51.5 [8.5] years, 54.3% male, 94.6% white) from the Wisconsin Sleep Cohort (WSC) – evaluated the relationship between time spent in REM sleep and mortality. The WSC cohort was younger, had a mix of men and women, and had more obesity, among other differences. The percentage of time spent in REM sleep was similar across the two cohorts, 19.2±6.6% among the MrOS group and 17.6±6.5% among the WSC group. Among the MrOS group, every 5% reduction in REM sleep was associated with a 13% higher rate of all-cause mortality (HR 1.13, 95% CI 1.08 to 1.19) after adjustment, the significance of which persisted for cardiovascular-related morality but not for cancer-related morality. Individuals experiencing less than 15% REM sleep per night had a significantly higher risk for all mortality definitions studied. Among the WSC cohort, the significant increase in all-cause mortality with reduction in REM sleep was also seen (HR 1.17, 95% CI 1.03 to 1.34) despite the differences in baseline characteristics. This robust study across two independent cohorts revealed an association between the amount of time spent in REM sleep and mortality, highlighting the need for clinical strategies to preserve and promote REM sleep.

Click to read the study JAMA Neurology

Image: PD

RELATED REPORTS

2 Minute Medicine Rewind July 14, 2025

Digital health apps may have limited role in reduction of migraine symptoms

SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: neurologysleep
Previous Post

Antibody testing may provide diagnostic support for SARS-CoV-2 infection

Next Post

Association of rapid eye movement sleep with mortality in middle-aged and older adults

RelatedReports

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Weekly Rewinds

2 Minute Medicine Rewind July 14, 2025

July 14, 2025
Patients with advanced adenomas are at increased risk of developing colorectal cancer
Chronic Disease

Digital health apps may have limited role in reduction of migraine symptoms

July 13, 2025
Cardiology

SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure

July 11, 2025
Age and number of islet autoantibodies associated with diabetes risk
Neurology

Inebilizumab improves outcome in patients generalized myasthenia gravis

July 10, 2025
Next Post
Association of rapid eye movement sleep with mortality in middle-aged and older adults

Association of rapid eye movement sleep with mortality in middle-aged and older adults

Rapid time to revascularization after ischemic stroke associated with improved functional outcomes

Ticagrelor and aspirin taken post stroke may decrease the risk of recurrent stroke

Quick Take: Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent)

Roflumilast effective for treatment of chronic plaque psoriasis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes
  • Glucagon-like peptide-1 receptor agonists may increase risk of reflux in patients with type 2 diabetes
  • Vaporized nicotine products may be effective for smoking cessation among people with social disadvantage
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.